Form 4 for ENVX Enovix Corp
Accepted 2021-07-16 00:00:00 ET · period of report 2021-07-14 · accession 0001209191-21-047045 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-16 | 2021-07-14 | ENVX | Lahiri Ashok | CTO | A - Grant | — | +1.35M | 1.35M | New | — |
| DM | 2021-07-16 | 2021-07-14 | ENVX | Lahiri Ashok | CTO | A - Grant | — | +162.9K | 21.5K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-14 | A | A | 1,351,031 | — | 1,351,031 | D | — | — | (F1) Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation. |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-07-14 | A | A | 141,376 | — | 141,376 | D | $9.26 · — to 2031-04-19 | 141,376 Common Stock | (F5) Received in exchange for a stock option to purchase 765,800 shares of Legacy Enovix Common Stock. (F4) The shares subject to the option are immediately exercisable. 1/120th of the shares subject to the option vest monthly over 4 years beginning on the vesting commencement date, April 18, 2021, and 1/20th of the shares subject to the option vest monthly thereafter over the next year, subject to Reporting Person's continuous service through each such vesting date. |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-07-14 | A | A | 21,538 | — | 21,538 | D | $0.05 · — to 2027-12-13 | 21,538 Common Stock | (F3) Received in exchange for a stock option to purchase 116,667 shares of Legacy Enovix Common Stock. (F2) The shares subject to the option vest in 48 equal monthly installments beginning on the vesting commencement date, September 1, 2017, subject to Reporting Person's continuous service through each such vesting date. |